Cereno Scientific publishes the interim report for Q3 2023 (July 1 – September 30)
The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q3 2023 (July 1 – September 30).Summary of the interim report for Q3 2023 (July 1 – September 30) Cereno Scientific Group · Result after financial items was SEK -11,076,974 (-7,248,364) · Earnings per share was SEK -0.05 (-0.06) before dilution and SEK -0.05 (-0.04) after dilution · The equity/assets ratio was 95.4% (93.2%) · Cash and bank balance was SEK 68,455,542 SEK (36,569,272) Parent company · Result after financial items was SEK -11,076,973 (-7,215,192) ·